FDA Approves Cresemba for Serious Fungal Infections

Share this content:
FDA Approves Cresemba for Serious Fungal Infections
FDA Approves Cresemba for Serious Fungal Infections

MONDAY, March 9, 2015 (HealthDay News) -- Cresemba (isavuconazonium sulfate) has been approved by the U.S. Food and Drug Administration to treat invasive aspergillosis and invasive mucormycosis, the agency said Friday in a news release.

These rare but serious fungal infections mostly affect people with weakened immune systems. The new drug, targeting the cell walls of the fungi, is available in oral and intravenous formulations.

Cresemba's safety and effectiveness were evaluated in clinical studies involving more than 500 people. The most common side effects included nausea, vomiting, diarrhea, headache, hypokalemia, constipation, dyspnea, coughing, and peripheral edema. More serious adverse effects could include liver problems and allergic reactions.

"Today's approval provides a new treatment option for patients with serious fungal infections and underscores the importance of having available safe and effective antifungal drugs," Edward Cox, M.D., M.P.H, director of the Office of Antimicrobial Products in the FDA's Center for Drug Evaluation and Research, said in a statement.

Cresemba is marketed by Astellas Pharma US, based in Northbrook, Ill.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

CDC: No Change in Level of Uninsured in U.S. in 2017

CDC: No Change in Level of Uninsured in ...

Five percent of children uninsured in 2017, 41.3 and 55.0 percent had public and private coverage

Age-Related Racial Disparity Examined in Childhood Suicide

Age-Related Racial Disparity Examined in Childhood Suicide

Significantly higher incidence of suicide for black children aged 5 to 12; lower rate for black teens

Moral Distress for Docs Providing Emergency-Only Hemodialysis

Moral Distress for Docs Providing Emergency-Only Hemodialysis

Docs describe burnout and emotional exhaustion; moral distress at seeing suffering and injustice

is free, fast, and customized just for you!

Already a member?

Sign In Now »